Skip to main content

Year: 2020

Meddelelse om forslag om afvikling af afdelingen FX Alpha II KL under Kapitalforeningen Jyske Portefølje

Bestyrelsen i Kapitalforeningen Jyske Portefølje har på bestyrelsesmøde den 11.november 2020 besluttet at indstille afviklingen af FX Alpha II KL i henhold til §§ 140 og 141 i Lov om alternative investeringsfonde mv.Den ekstraordinære generalforsamling vil blive indkaldt ved separat meddelelse.Vedhæftet fil24 – 2020 11 11 Selskabsmeddelelse Beslutning om at indstille til afvikling af afdelingen FX Alpha II KL

Continue reading

UPDATE – Castor Maritime Inc. Reports Financial Results for the Three Months and Nine Months Ended September 30, 2020

LIMASSOL, Cyprus, Nov. 11, 2020 (GLOBE NEWSWIRE) — Castor Maritime Inc. (NASDAQ: CTRM), (“Castor” or the “Company”), a global shipping company specializing in the ownership of dry bulk vessels, today announced its results for the three months and nine months ended September 30, 2020.Highlights of the Three Months Ended September 30, 2020:Revenues, net: $2.8 million for the three months ended September 30, 2020, as compared to $1.2 million for the three months ended September 30, 2019, or a 133% period to period increase;Net (loss)/income: Net loss of $580,153 for the three months ended September 30, 2020, as compared to net income of $244,229 for the three months ended September 30, 2019;Loss per share: 0.47 cent loss per share for the three months ended September 30, 2020, as compared to a loss per share of 2 cents for the three...

Continue reading

Medigus: Matomy Signed Merger Agreement with Vehicle Importer Global Automax

OMER, Israel, Nov. 11, 2020 (GLOBE NEWSWIRE) — Medigus Ltd. (Nasdaq:MDGS) (TASE:MDGS), a technology company engaged in advanced medical solutions and innovative internet technologies, today announced that Matomy Media Group Ltd. (LSE: MTMY, TASE: MTMY.TA), a Medigus affiliated company (24.92% owned), entered into a merger agreement with Global Automax Ltd., by way of an exchange of shares between Matomy and shareholders of Global Automax.Global AutoMax is an Israeli private company engaged in the import of a variety of leading automobile brands into Israel. Global AutoMax imports models by Toyota, FCA (Jeep, Chrysler and Fiat), Mercedes-Benz, Hyundai, Volkswagen, Volvo and Ford. Medigus was informed by Matomy that Global Automax sold approximately 3,000 vehicles in 2019 with a turnover of NIS 355 million.According to the merger...

Continue reading

Invesco ltd: Form 8.3 – CPL Resources Plc

                                               Form 8.3IRISH TAKEOVER PANELDISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE1.       KEY INFORMATIONINTERESTS AND SHORT POSITIONS Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)DEALINGS (Note 4) Purchases and sales(b)      Derivatives transactions (other than options transactions)(c)      Options transactions in respect of existing relevant securities(i)       Writing, selling, purchasing or varying(ii)      Exercising(d)      Other dealings (including transactions in respect of new securities) (Note 4)    2.      ...

Continue reading

A Personal Loan Aligned With Your Goals

Whenever we are in need of funds, we think about a personal loan. It can help with our personal and professional needs. The loan is designed keeping the changing demands of borrowers in mind and offers a complete solution for our needs. If you are in need of funds, apply for the Hero FinCorp personal loan today. The loan will help turn your dreams into a reality and will allow you to make the most of a business opportunity. Hero FinCorp is a well-known name in the industry with a strong presence across the length and breadth of the country. Considered as one of the most reliable lenders in the industry, Hero FinCorp has a high loan amount and flexible repayment tenure. The lender strives to help individuals in distress and offers loan products for personal and business needs. Identify the purpose of borrowing and then estimate the amount...

Continue reading

Skeena Resources Announces Pricing of Upsized C$40.0 Million Common Share Public Offering

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATESVANCOUVER, British Columbia, Nov. 11, 2020 (GLOBE NEWSWIRE) — Skeena Resources Limited (TSX: SKE, OTCQX: SKREF) (“Skeena” or the “Company”) is pleased to announce that further to its previously announced overnight marketed public offering (the “Offering”) of common shares of the Company (the “Common Shares”), it has entered into an underwriting agreement with a syndicate of underwriters co-led by Raymond James Ltd. and Canaccord Genuity Corp., and including Clarus Securities Inc., Sprott Capital Partners and RBC Capital Markets (collectively the “Underwriters”) to sell 17,021,277 Common Shares at a price of $2.35 per share (the “Offering Price”) for upsized...

Continue reading

Telos Corporation Announces Launch of IPO

ASHBURN, Va., Nov. 11, 2020 (GLOBE NEWSWIRE) — Telos ® Corporation (“Telos” or the “Company”), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, today announced the launch of its initial public offering of 12,352,942 primary shares of its common stock. The underwriters will have a 30-day option to purchase up to an additional 1,852,941 shares of common stock from the Company. Telos intends to list its common stock on the NASDAQ Global Market, under the ticker symbol “TLS.”B. Riley Securities, BMO Capital Markets, and Needham & Company are acting as joint bookrunners for the proposed offering. Colliers Securities LLC, D.A. Davidson & Co., Northland Capital Markets, Wedbush Securities, and MKM Partners will serve as co-managers for the offering.The...

Continue reading

J. Knipper and Company, Inc. Finalizes Acquisition of Eagle Pharmacy to Expand Company’s Pharmacy Programs, Scale and Automation Capabilities

One of the Largest Suppliers of Pharmaceutical Marketing Solutions and Specialty Pharmacy Services in the U.S. Closes Transaction to Acquire Full-Service, Direct-to-Patient Online PharmacyLAKEWOOD, N.J., Nov. 11, 2020 (GLOBE NEWSWIRE) — J. Knipper and Company, Inc., one of the largest suppliers of end-to-end pharmaceutical healthcare marketing services and solutions in the U.S., and its affiliates, including KnippeRx, announced today the Company has finalized a transaction to acquire Eagle Pharmacy, LLC, a full-service, direct-to-patient (DTP) pharmacy based in Lakeland, Florida.“Eagle Pharmacy represents a strategic acquisition for Knipper to accelerate delivery on its mission to enhance the patient journey and create the shortest distance between patient and therapy by offering customized pharmacy solutions to pharmaceutical manufacturers,...

Continue reading

CORRECTING and REPLACING — Performance Shipping Inc. Announces Agreement to Acquire Fifth Aframax Tanker

ATHENS, Greece, Nov. 11, 2020 (GLOBE NEWSWIRE) — In the release issued today by Performance Shipping Inc. (NASDAQ: PSHG), we were informed by the client the ticker symbol should be PSHG and not DCIX. The corrected text follows.Performance Shipping Inc. (NASDAQ: PSHG), (the “Company”), a global shipping company specializing in the ownership of tankers, today announced that it has signed, through a separate wholly-owned subsidiary, a Memorandum of Agreement to purchase the M/T Kalamas, a 105,400 dwt Aframax tanker vessel built in 2011 by Sumitomo Heavy Industries Marine & Engineering Co. Ltd, Japan, from an unaffiliated third party seller for a total purchase price of US$22.0 million. The vessel, the Company’s fifth Aframax tanker, is expected to be delivered between November 15 and December 22, 2020, and will be renamed M/T P....

Continue reading

Shattuck Labs Announces Preclinical Proof of Concept Study on Gamma Delta T Cell Engager, GADLEN™, Platform at SITC 2020

AUSTIN, TX and DURHAM, NC, Nov. 11, 2020 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today announced the presentation of preclinical data from its Gamma Delta T Cell Engager, or GADLEN™, platform. The presentation, titled “In vivo expansion of gamma delta T cells by a CD19-targeted butyrophilin heterodimer leads to elimination of peripheral B cells”, will be presented by Suresh de Silva, Ph.D., VP of Product Development at Shattuck, at the Society for Immunotherapy of Cancer’s (SITC) 35th Anniversary Annual Meeting, which is being held virtually November 9-14, 2020. The GADLEN platform is a novel class of...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.